In this article, we will discuss about Cetuximab (Indications). So, let's get started. Indications Cetuximab (ERBITUX®) is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of: Head and Neck Cancer • Locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy. • Recurrent locoregional disease or … Continue reading Cetuximab